Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Avinger, Inc. AVGR NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
17/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Avinger, Inc. (AVGR) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 4 Buy, 3 Hold.

AVGR Analyst Ratings

Buy
7
Ratings
4 Buy
3 Hold
Based on 7 analysts giving stock ratings to Avinger, Inc. in the past 3 months
Rating breakdown
Buy
4 57%
Hold
3 43%
57%
Buy
4 analysts
43%
Hold
3 analysts
0%
Sell
0 analysts

People Also View

ATR
ATR
AptarGroup, Inc.
$131.01
-0.83%
 ICUI
ICUI
ICU Medical, Inc.
$127.85
-1.14%
 ATRC
ATRC
AtriCure, Inc.
$29.40
+2.58%
 ATRI
ATRI
Atrion Corporation
$459.92
+0.06%
 ANGO
ANGO
AngioDynamics, Inc.
$10.47
+2.25%
 KRMD
KRMD
KORU Medical Systems, Inc.
$4.30
-0.92%
 PDEX
PDEX
Pro-Dex, Inc.
$52.77
+0.71%
 AKYA
AKYA
Akoya Biosciences, Inc.
$1.29
-5.15%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message